Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Scandinavian Journal of Urology and Nephrology
|
May 31, 2003
Presence and significance of TT virus in Danish patients on maintenance hemodialysis
Trine Boysen, Jens K Christensen, Chris D Madsen, et al.
Scandinavian Journal of Gastroenterology
|
June 8, 2012
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C
Peer Brehm Christensen, Henrik Bygum Krarup, Alex Lund Laursen, et al.
European Journal of Endocrinology
|
March 16, 2022
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
Kim Huynh, Marianne Klose, Kim Krogsgaard, et al.
Plos One
|
January 31, 2019
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
Jürgen K Rockstroh, David Asmuth, Giuseppe Pantaleo, et al.
The Lancet. HIV
|
September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens
|
September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S Søgaard, Mette E Graversen, Steffen Leth, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Scandinavian Journal of Urology and Nephrology
|
May 31, 2003
Presence and significance of TT virus in Danish patients on maintenance hemodialysis
Trine Boysen, Jens K Christensen, Chris D Madsen, et al.
Scandinavian Journal of Gastroenterology
|
June 8, 2012
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C
Peer Brehm Christensen, Henrik Bygum Krarup, Alex Lund Laursen, et al.
European Journal of Endocrinology
|
March 16, 2022
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
Kim Huynh, Marianne Klose, Kim Krogsgaard, et al.
Plos One
|
January 31, 2019
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
Jürgen K Rockstroh, David Asmuth, Giuseppe Pantaleo, et al.
The Lancet. HIV
|
September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens
|
September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S Søgaard, Mette E Graversen, Steffen Leth, et al.
Page
of 3